With expanded carrier screening, founder populations run the risk of being overlooked

Inge B Mathijssen1, Merel C van Maarle2, Iris I M Kleiss2

  • 1Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands. i.b.mathijssen@amc.uva.nl.